You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 9,572,779


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,572,779
Title:Encased tamper resistant controlled release dosage forms
Abstract: In certain embodiments, the present invention is directed to a solid controlled release dosage form comprising: a core comprising a first portion of an opioid analgesic dispersed in a first matrix material; and a shell encasing the core and comprising a second portion of the opioid analgesic dispersed in a second matrix material; wherein the amount of opioid analgesic released from the dosage form is proportional within 20% to elapsed time from 8 to 24 hours, as measured by an in-vitro dissolution in a USP Apparatus 1 (basket) at 100 rpm in 900 ml simulated gastric fluid without enzymes (SGF) at 37 C.
Inventor(s): Huang; Haiyong Hugh (Princeton, NJ)
Assignee: Purdue Pharma L.P. (Stamford, CT)
Application Number:15/045,962
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,572,779
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,572,779: A Comprehensive Analysis

Introduction

Patent 9,572,779, like any other patent, is a complex document that outlines the scope and claims of an invention. To fully understand its implications, it is crucial to delve into the specifics of the patent claims, the patent landscape, and the relevant legal frameworks.

Patent Claims: An Overview

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected under the patent. For U.S. Patent 9,572,779, the claims would typically include independent and dependent claims that outline the novel and non-obvious aspects of the invention.

Independent Claims

Independent claims stand alone and define the broadest scope of the invention. They are crucial because they set the boundaries of what is considered novel and non-obvious. For example, if a patent involves a method for enhancing audio signals, an independent claim might include the steps of receiving audio input, separating the audio signals, and applying mathematical algorithms to enhance clarity, similar to the examples provided in the 2024 USPTO guidance update[1].

Dependent Claims

Dependent claims build upon the independent claims and provide additional limitations that narrow the scope of the invention. These claims are often used to add specific details or applications that make the invention more practical and useful. For instance, a dependent claim might specify the use of the enhanced audio signals in a speech recognition system to improve voice command accuracy in hands-free environments[1].

Subject Matter Eligibility

A critical aspect of patent claims is ensuring they meet the criteria for subject matter eligibility under U.S. patent law. This involves evaluating whether the claims integrate judicial exceptions (such as abstract ideas or natural phenomena) into practical applications.

Abstract Ideas and Practical Applications

Claims that merely involve abstract ideas, such as manipulating information using mathematical techniques, are not eligible for patent protection unless they are integrated into a practical application. For example, Claim 1 in the 2024 USPTO guidance update, which involves routine data processing steps without a practical application, would not be eligible. However, Claim 2, which specifies the use of separated audio components in a real-time speech recognition system, would be eligible because it provides a meaningful limit and integrates the judicial exception into a practical application[1].

Determining Inventorship

Inventorship is a legal matter that is distinct from authorship or team contributions. The true and only inventors must be identified and listed in the patent application.

Conception and Reduction to Practice

Inventorship involves two key steps: the conception of the idea and the reduction of the idea to practice. Conception is complete when the idea is sufficiently definite and permanent to permit one with ordinary skill in the field to reduce it to practice without undue experimentation[2].

Correcting Errors in Inventorship

Errors in inventorship can be corrected, but deceptive intent can render the patent invalid and unenforceable. Ensuring the correct identification of inventors is paramount to maintaining the enforceability of the patent[2].

Patent Scope and Quality

The scope of a patent is a critical factor in determining its quality and validity. Metrics such as independent claim length and independent claim count can be used to measure patent scope.

Metrics for Measuring Patent Scope

Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. Broader claims, on the other hand, can lead to increased licensing and litigation costs, diminishing incentives for innovation[3].

The Patent Landscape

Understanding the broader patent landscape is essential for navigating the complexities of patent law.

Global Dossier and Public Search Facilities

Tools like the Global Dossier and the USPTO Public Search Facility provide access to patent and trademark information, allowing users to track related applications and office actions. These resources are invaluable for patent practitioners and innovators[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and complexity. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes[5].

Practical Applications and Real-World Benefits

To ensure patent eligibility, it is crucial to highlight the real-world applications and benefits of the claimed invention.

Example: Enhanced Audio Signals

For a patent involving enhanced audio signals, specifying the use of these signals in a real-time speech recognition system to improve voice command accuracy in hands-free environments demonstrates a practical application. This provides tangible benefits such as improved noise reduction, enhanced accuracy in speech recognition, and better performance in voice-controlled systems[1].

Key Takeaways

  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be eligible for patent protection.
  • Inventorship: Correct identification of true and only inventors is crucial for maintaining patent enforceability.
  • Patent Scope: Narrower claims are generally associated with higher grant probabilities and shorter examination processes.
  • Practical Applications: Highlighting real-world benefits and applications is essential for demonstrating patent eligibility.
  • Patent Landscape: Utilizing tools like the Global Dossier and Public Search Facilities can aid in navigating the patent landscape.

FAQs

Q: What is the significance of subject matter eligibility in patent claims?

A: Subject matter eligibility ensures that patent claims do not cover abstract ideas or natural phenomena without a practical application, making the invention patent-eligible.

Q: How is inventorship determined in U.S. patent law?

A: Inventorship is determined by identifying those who conceived the idea and reduced it to practice, with a focus on the conception step.

Q: What metrics can be used to measure patent scope?

A: Metrics such as independent claim length and independent claim count can be used to measure patent scope and assess the quality of the patent.

Q: What is the purpose of the Global Dossier?

A: The Global Dossier provides access to file histories of related applications from participating IP Offices, aiding in the management and analysis of patent families.

Q: Why is it important to specify practical applications in patent claims?

A: Specifying practical applications helps to transform abstract ideas into patent-eligible inventions by demonstrating tangible benefits and real-world uses.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent: Mintz, July 25, 2024.
  2. Determining Inventorship for US Patent Applications: Oregon State University, AgSci.
  3. Patent Claims and Patent Scope: SSRN, September 29, 2016.
  4. Search for patents - USPTO: USPTO.
  5. U.S. Patent Small Claims Court: Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,572,779

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Purdue Pharma Lp HYSINGLA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 206627-001 Nov 20, 2014 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Purdue Pharma Lp HYSINGLA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 206627-002 Nov 20, 2014 AB RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Purdue Pharma Lp HYSINGLA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 206627-003 Nov 20, 2014 AB RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Purdue Pharma Lp HYSINGLA ER hydrocodone bitartrate TABLET, EXTENDED RELEASE;ORAL 206627-004 Nov 20, 2014 AB RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.